Antibiotic Prophylaxis, Antibiotic Resistance, Recurrent Urinary Tract Infections
Conditions
Keywords
recurrent urinary tract infections, d mannose prophylaxis, antibiotic prophylaxis
Brief summary
The aim of this review is to address clinical reliability, efficacy and safety of long-term treatment with oral D Mannose for the prevention of recurrent urinary tract infections (RUTIs) in females.
Detailed description
A comprehensive systematic MEDLINE, Embase, Cochrane search was performed for English language reports published before December 2018 using the term recurrent urinary tract infections and d mannose. We searched Medline, Embase, and the Cochrane Register of Controlled Trials since January 2010 to December 2018. Eligible studies did not include non-oral therapy, local (vaginal) treatment in women with RUTIs. Study eligibility criteria- We identified eligible original articles. The heterogeneity of the available studies, their different rationale and aim, the assumption of d mannose for prophylaxis or treatment of recurrent UTIs need to be taken into account.
Interventions
OTHERsystematic review
Sponsors
Fondazione IRCCS Policlinico San Matteo di Pavia
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
recurrent urinary tract infections (RUTIs)
Exclusion criteria
Upper urinary tract infections, severe clinical symptoms, fever \> 37,5 with lumbar pain
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| research literature data on d mannose for prevention and treatment of recurrent urinary tract infections. | January 2010-December 2018 | literature search of the Medline, Embase, and Cochrane Library databases |
Countries
Italy
Outcome results
None listed